PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 109 filers reported holding PMV PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $736,827 | -45.2% | 154,471 | 0.0% | 0.54% | -34.3% |
| Q4 2022 | $1,343,898 | -26.9% | 154,471 | -0.0% | 0.83% | +4.4% |
| Q3 2022 | $1,839,000 | -15.4% | 154,500 | +1.3% | 0.79% | -34.6% |
| Q2 2022 | $2,173,000 | -55.7% | 152,500 | -35.2% | 1.21% | -47.1% |
| Q1 2022 | $4,903,000 | +975.2% | 235,500 | +1599.6% | 2.29% | +1297.0% |
| Q1 2021 | $456,000 | -50.6% | 13,856 | -7.6% | 0.16% | -34.7% |
| Q4 2020 | $923,000 | – | 15,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $74,726,000 | 44.17% |
| Euclidean Capital LLC | 2,336,909 | $53,983,000 | 30.69% |
| OUP Management Co., LLC | 989,232 | $22,851,000 | 10.30% |
| Nextech Invest Ltd. | 1,385,807 | $32,012,000 | 8.43% |
| Boxer Capital, LLC | 2,838,236 | $65,563,000 | 2.55% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $12,713,000 | 2.38% |
| Orbimed Advisors | 7,330,423 | $169,333,000 | 2.18% |
| Asymmetry Capital Management, L.P. | 97,680 | $2,256,000 | 1.20% |
| RTW INVESTMENTS, LP | 2,980,960 | $68,860,000 | 1.01% |
| HighVista Strategies LLC | 39,777 | $919,000 | 0.73% |